Polycystic ovary syndrome and congenital adrenal hyperplasia: A different entity for comparable phenotypes?;Syndrome des ovaires polykystiques et syndrome adrenogenital: Une entité différente pour un phénotype comparable?

Revue Medicale Suisse

Volumn 3, Issue 116, 2007, Pages 1595-1601

  Robyr, Damien ^a   Llor, Juan ^b   Gaudin, Georges ^b   Schneider, Nicolas ^c  

^a Hôpital de Sion ^*  (Switzerland)

^b Hopital de Sion   (Switzerland)

^c Hopital de Martigny   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HORMONE; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ADRENAL GLAND; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; HIRSUTISM; HUMAN; HYPOPHYSIS; INFERTILITY; MENSTRUATION DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREGNANCY; REVIEW; ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETICS; NEWBORN;

ADRENAL HYPERPLASIA, CONGENITAL; ADRENOGENITAL SYNDROME; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; STEROID 21-HYDROXYLASE;

EID: 34447623390     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006;91:2100-4.
2. * Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome : Clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005;83:1717-23.
3. Hahn S, Tan S, Elsenbruch S, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005;37:438-44.
4. Clayton RN, Ogden V, Hodgkinson J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992;37:127-34.
5. Fratantonio E,Vicari E, Pafumi C, Calogero AE. Genetics of polycystic ovarian syndrome. Reprod Biomed Online 2005;10:713-20.
6. Doi SA,Al-Zaid M,Towers PA, Scott CJ,Al-Shoumer KA. Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 2006 Jun 15; Epub ahead of print.
7. Starka L, Duskova M, Cermakova I,Vrbikova J, Hill M. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? Endocr Regul 2005;39:127-31.
8. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005;365:2125-36.
9. ** Speiser PW,White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;34:776-88. Review.
10. Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy : Challenges in disease detection and treatment. Endocr Rev 2005;26:775-99.
11. Varness TS,Allen DB, Hoffman GL. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J Pediatr 2005;147:493-8.
12. Votava F,Torok D, Kovacs J, et al. Middle European Society for Paediatric Endocrinology - Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia. Eur J Endocrinol 2005;152:869-74.